UK-based clinical and cell ag company 3D Bio-Tissues (3DBT) has recently expanded internationally with a new office in Hong Kong to introduce its flagship cell-boosting media supplement, City-Mix, to the Chinese cultivated meat market.
3DBT will also target the Chinese biotech industry, especially gene therapy, stem cells, regenerative medicine, Life Sciences companies, and academia. The company already started hiring R&D experts and sales and marketing specialists to develop a go-to-market strategy, build distribution networks, and establish manufacturing partners in China.
The announcement was made by the biotech investor BSF Enterprise (LSE: BSFA), which owns 3DBT. Recently, BSF raised £2.9 million to provide working capital for its subsidiary to accelerate its progress and develop systems to expedite the production and supply of its media growth and target manufacturers.
** Click here to read the full-text **
